rs372261958
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001145809.2(MYH14):c.5128-12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000507 in 1,598,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000050 ( 0 hom. )
Consequence
MYH14
NM_001145809.2 intron
NM_001145809.2 intron
Scores
2
Splicing: ADA: 0.00001950
2
Clinical Significance
Conservation
PhyloP100: -0.894
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-50292249-C-T is Benign according to our data. Variant chr19-50292249-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 164204.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50292249-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH14 | NM_001145809.2 | c.5128-12C>T | intron_variant | ENST00000642316.2 | NP_001139281.1 | |||
MYH14 | NM_001077186.2 | c.5029-12C>T | intron_variant | NP_001070654.1 | ||||
MYH14 | NM_024729.4 | c.5005-12C>T | intron_variant | NP_079005.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152146Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
9
AN:
152146
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000260 AC: 6AN: 231134Hom.: 0 AF XY: 0.0000239 AC XY: 3AN XY: 125526
GnomAD3 exomes
AF:
AC:
6
AN:
231134
Hom.:
AF XY:
AC XY:
3
AN XY:
125526
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000498 AC: 72AN: 1446260Hom.: 0 Cov.: 31 AF XY: 0.0000501 AC XY: 36AN XY: 717880
GnomAD4 exome
AF:
AC:
72
AN:
1446260
Hom.:
Cov.:
31
AF XY:
AC XY:
36
AN XY:
717880
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74312
GnomAD4 genome
AF:
AC:
9
AN:
152146
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 22, 2013 | 5128-12C>T in Intron 36 of MYH14: This variant is not expected to have clinical significance because it does not diverge from the splice consensus sequence and computational prediction tools do not suggest an impact to splicing. This varian t has been identified in 1/4148 (0.02%) African American chromosomes by the NHLB I Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs372261958 ). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at